Glaucoma is one of the leading causes of irreversible vision loss, often progressing silently before symptoms are noticeable. At London Ophthalmology Centre (LondonOC), laser treatments such as Selective Laser Trabeculoplasty (SLT) and Argon Laser Trabeculoplasty (ALT) play a key role in controlling intraocular pressure (IOP) and preserving sight.
SLT is a modern, minimally invasive laser procedure that targets the trabecular meshwork — the eye’s drainage system. By stimulating the eye to improve fluid outflow, SLT helps reduce IOP without surgery or incisions. It is generally painless, performed under local anaesthetic, and allows most patients to return home the same day. For many, it can reduce or even replace the need for long-term glaucoma eye drops.
ALT, although an older laser technique, remains effective in carefully selected patients. It uses argon laser energy to improve drainage, lowering IOP and slowing glaucoma progression. Both SLT and ALT can be repeated safely if necessary, making them versatile options in ongoing glaucoma management.
The choice between SLT and ALT is highly personalised. At LondonOC, consultant ophthalmologists like Mr. Vik Sharma carefully assess each patient’s eye health, glaucoma type, and previous treatments to recommend the most suitable approach. Early intervention with laser therapy can significantly slow disease progression, protect vision, and improve quality of life.
In addition to their therapeutic benefits, laser procedures have fewer risks compared to traditional glaucoma surgery. Complications are rare, recovery is quicker, and patients often experience minimal discomfort.
For anyone concerned about their eye pressure, or for those who wish to explore alternatives to daily medications, laser treatment may be an ideal solution. By seeking care at a consultant-led specialist centre, patients gain access to the latest techniques, experienced surgeons, and personalised treatment plans.